Keywords
steroid 17-alpha-Hydroxylase
virilism
hypertension
sexual development
mutation
How to Cite
Abstract
Introduction: a defect in the CYP17A1 gene causes 17?-Hydroxylase/17,20-lyase deficiency. It encodes an enzyme that expresses both 17?-hydroxylase and 17,20-lyase activity in the adrenal glands and gonads. The phenotype of this condition is characteristic but may be shared by other enzyme defects. Therefore, the adequate genotype-phenotype relationship is essential for the correct diagnosis, to focus the treatment and the counseling of patients.
Case objective: To report for the first time a genetic variant potentially related to congenital adrenal hyperplasia in a patient with a phenotype compatible with a deficiency of 17?-hydroxylase and 17,20-lyase.
Case presentation: We present the case of a woman who consulted for sexual infantilism and primary amenorrhea in the presence of a 46XX karyotype. She developed hypertension and hypokalemia, which led to the diagnostic suspicion of congenital adrenal hyperplasia (CAH). A genetic study revealed a homozygous missense mutation in exon 8, c.1250 T>C; p. Phe417Ser of the CYP17A1 gene. Mutations in this location have previously been shown to suppress 17?-hydroxylase and 17,20-lyase activities, which could explain the observed phenotype. We report the missense mutation, c.1250 T>C; p. Phe417Ser, for the first time in the CYP17A1 gene related to HAC.
Conclusion: Genetic analyses in all patients with HAC are necessary to define the frequency of this and other mutations in the Colombian population and relate the disease's phenotype with its genotype.
References
El-Maouche D, Arlt W, Merke DP. Congenital adrenal hyperplasia. Lancet. 2017;390(10108):2194–210.
Turcu AF, Auchus RJ. Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia. Endocrinol Metab Clin North Am. 2015;44(2):275–96.
Miller WL. Rare defects in adrenal steroidogenesis. Eur J Endocrinol. 2018;179(3): R125–41.
Biglieri EG, Herron MA, Brust N. 17-Hydroxylation Deficiency in Man *. 1966;45(12):1946–54.
Hinz L, Pacaud D, Kline G. Congenital adrenal hyperplasia causing hypertension: An illustrative review. J Hum Hypertens. 2018;32(2):150–7.
Auchus RJ. Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic. J Steroid Biochem Mol Biol. 2017; 165:71–8.
Picado-Leonard J, Miller WL. Cloning and Sequence of the Human Gene for P450cl7 (Steroid 17?-Hydroxylase/17,20 Lyase): Similarity with the Gene for P450c21. Dna. 1987;6(5):439–48.
Durán-pérez EG, Lourdes M De, Segovia-palomo A, Sánchez-pedraza V, Kofman-alfaro S, Arellano-montaño S, et al. Desórdenes de la diferenciación sexual por mutaciones en CYP17. 2009;17(4):153–60.
Adlyne Reena Asirvatham, Karthik Balachandran, Packiamary Jerome, Vettriselvi Venkatesan, Teena Koshy, Shriraam Mahadevan. Clinical, biochemical and genetic characteristics of children with congenital adrenal hyperplasia due to 17?-hydroxylase deficiency. J Pediatr Endocrinol Metab. 2020; 33(8): 1051–1056.
Costa-Santos M, Kater CE, Auchus RJ. Two Prevalent CYP17 Mutations and Genotype-Phenotype Correlations in 24 Brazilian Patients with 17-Hydroxylase deficiency. J Clin Endocrinol Metab. 2004;89(1):49–60.
Han B, Cheng T, Zhu H, Yu J, Zhu WJ, Song HD, et al. Genetic Analysis of 25 Patients with 5 ? -Reductase Deficiency in Chinese Population. Biomed Res Int. 2020;2020.
Sparkes RS, Klisak I, Miller WL. Regional Mapping of Genes Encoding Human Steroidogenic Enzymes: P450scc to 15q23–q24, Adrenodoxin to 11q22; Adrenodoxin Reductase to 17q24–q25; and P450c17 to 10q24–q25. DNA Cell Biol. 1991;10(5):359–65.
Kim YM, Kang M, Choi JH, Lee BH, Kim GH, Ohn JH, et al. A review of the literature on common CYP17A1 mutations in adults with 17-hydroxylase/17,20-lyase Deficiency, a case series of such mutations among Koreans and functional characteristics of a novel mutation. Metabolism. 2014;63(1):42–9.
Zhou Y, Xue X, Shi P, Lu Q, Lv S. Multidisciplinary team management of 46, XY 17?-hydroxylase deficiency: a case report and literature review. J Int Med Res. 2021;49(3).
Chen H, Yuan K, Zhang B, Jia Z, Chen C, Zhu Y, et al. A Novel Compound Heterozygous CYP17A1 Variant Causes 17?-Hydroxylase/17, 20-Lyase deficiency. Front Genet. 2019;10(October):1–9.
Escamilla-Márquez MA, Garduño-Garcia JDJ, Ordóñez-Sánchez ML, Reza-Albarrán A, Tusie-Luna MT, Gómez Pérez FJ, et al. Primary amenorrhea in two sisters: Description of a Mexican family with 17? hydroxylase-17 lyase deficiency caused by arginine stop mutation. Gynecol Endocrinol. 2012;28(9):733–5.
Biason-Lauber A, Leiberman E, Zachmann M. A single amino acid substitution in the putative redox partner-binding site of P450c17 as cause of isolated 17,20-lyase deficiency. J Clin Endocrinol Metab. 1997;82(11):3807–12.
Biason-lauber A, Kempken B, Werder E, Forest MG, Einaudi S, Ranke MB, et al. Study Enzymatic Activity Regulation: Role of Phosphorylation *. 2000;85(3):1226–31.
Gupta MK, Geller DH, Auchus RJ. Pitfalls in characterizing P450c17 mutations associated with isolated 17,20-lyase deficiency. J Clin Endocrinol Metab. 2001;86(9):4416–23.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2022 Revista Colombiana de Endocrinología, Diabetes & Metabolismo